Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer.

Balar, Arjun V; Apolo, Andrea B; Ostrovnaya, Irina; Mironov, Svetlana; Iasonos, Alexia; Trout, Alisa; Regazzi, Ashley M; Garcia-Grossman, Ilana R; Gallagher, David J; Milowsky, Matthew I; Bajorin, Dean F

Balar, Arjun V; Apolo, Andrea B; Ostrovnaya, Irina; Mironov, Svetlana; Iasonos, Alexia; Trout, Alisa; Regazzi, Ashley M; Garcia-Grossman, Ilana R; Gallagher, David J; Milowsky, Matthew I; Bajorin, Dean F.

Affiliation

Balar AV; Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

J Clin Oncol ; 31(6): 724-30, 2013 Feb 20.

Article in En | MEDLINE | ID: mdl-23341513

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Urologic Neoplasms/drug therapy; Urothelium/drug effects; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized/administration & dosage; Antibodies, Monoclonal, Humanized/adverse effects; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Bevacizumab; Carboplatin/administration & dosage; Carboplatin/adverse effects; Constipation/chemically induced; Deoxycytidine/administration & dosage; Deoxycytidine/adverse effects; Deoxycytidine/analogs & derivatives; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatigue/chemically induced; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Neutropenia/chemically induced; Treatment Outcome; Urologic Neoplasms/pathology; Urothelium/pathology; Gemcitabine

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Urologic Neoplasms / Urothelium Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2013 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google